Cytune Pharma, a biotechnology company owned by PPF Group, is responsible for the clinical development of SO-C101, SOTIO is a sponsor of the Phase 1 clinical trial.
| Website | http://www.cytunepharma.com |
| Employees | 2 (1 on RocketReach) |
| Founded | 2007 |
| Address | 3, Chemin du Pressoir Chênaie, Nantes, Pays de la Loire 44100, FR |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Drug Development, Pharma, Drug Discovery, Clinical Development, Pharmaceutical Research, Biopharma, Clinical Trials, Research, Therapeutics, Medicine, Biologics, Treatment, Healthcare, Oncology, Immunotherapy |
Looking for a particular Cytune Pharma employee's phone or email?
Gaëtan Decherf is the CEO of Cytune Pharma.
1 people are employed at Cytune Pharma.
Cytune Pharma is based in Nantes, Pays de la Loire.